CORONA Remedies Limited (NSE:CORONA)
1,697.00
-4.20 (-0.25%)
At close: May 26, 2026
CORONA Remedies Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 441.2 | 32.23 | 31.56 | 144.94 | 68.24 |
Short-Term Investments | - | 8.16 | 13.98 | 59.69 | 69.92 |
Cash & Short-Term Investments | 441.2 | 40.39 | 45.54 | 204.63 | 138.16 |
Cash Growth | 992.35% | -11.31% | -77.75% | 48.11% | -80.94% |
Accounts Receivable | 1,456 | 1,183 | 999.34 | 869.91 | 743.52 |
Other Receivables | - | 6.14 | 4.02 | 2.67 | 5.98 |
Receivables | 1,458 | 1,193 | 1,007 | 876.96 | 753.73 |
Inventory | 1,250 | 1,295 | 983.45 | 1,054 | 739.47 |
Prepaid Expenses | - | 37.03 | 33.85 | 27.59 | 17.3 |
Other Current Assets | 333.8 | 823.71 | 829.22 | 751.7 | 1,187 |
Total Current Assets | 3,483 | 3,389 | 2,899 | 2,915 | 2,836 |
Property, Plant & Equipment | 4,343 | 3,847 | 3,116 | 2,488 | 1,665 |
Long-Term Investments | 262.9 | 259.53 | 275 | 399.86 | 437.77 |
Other Intangible Assets | 2,628 | 1,712 | 1,927 | 5.34 | 95.3 |
Long-Term Deferred Tax Assets | - | - | - | 42.52 | 37.83 |
Other Long-Term Assets | 1,334 | 91.77 | 87.76 | 99.94 | 42.08 |
Total Assets | 12,051 | 9,299 | 8,306 | 5,950 | 5,114 |
Accounts Payable | 1,471 | 1,435 | 1,143 | 943.7 | 846 |
Accrued Expenses | - | 94.69 | 67.41 | 88.41 | 69.62 |
Short-Term Debt | - | 106.95 | 311.42 | 23.31 | 20.67 |
Current Portion of Long-Term Debt | 1,429 | 360 | 360 | - | 151.33 |
Current Portion of Leases | 31.1 | 25.2 | 21.65 | 17.92 | 58.43 |
Current Income Taxes Payable | 83.8 | 63.25 | 48.05 | 38.32 | 33.8 |
Other Current Liabilities | 597.5 | 310.61 | 290.44 | 262.05 | 298.61 |
Total Current Liabilities | 3,612 | 2,396 | 2,242 | 1,374 | 1,478 |
Long-Term Debt | - | 160 | 670 | - | 165.38 |
Long-Term Leases | 188.8 | 210.16 | 226.48 | 238.37 | 68.24 |
Long-Term Unearned Revenue | - | - | 0.14 | 4.91 | 4.91 |
Pension & Post-Retirement Benefits | - | 135.98 | 109.55 | 76.53 | 56.56 |
Long-Term Deferred Tax Liabilities | 121.6 | 82.95 | 42.86 | - | - |
Other Long-Term Liabilities | 660.7 | 250.16 | 210.74 | 171.52 | 131.02 |
Total Liabilities | 4,583 | 3,235 | 3,502 | 1,865 | 1,905 |
Common Stock | 611.6 | 611.6 | 611.6 | 611.6 | 510.51 |
Additional Paid-In Capital | - | 415.84 | 415.84 | 415.84 | 411.97 |
Retained Earnings | - | 5,036 | 3,777 | 3,058 | 2,283 |
Comprehensive Income & Other | 6,857 | - | - | - | - |
Total Common Equity | 7,469 | 6,063 | 4,804 | 4,085 | 3,205 |
Shareholders' Equity | 7,469 | 6,063 | 4,804 | 4,085 | 3,209 |
Total Liabilities & Equity | 12,051 | 9,299 | 8,306 | 5,950 | 5,114 |
Total Debt | 1,649 | 862.31 | 1,590 | 279.6 | 464.05 |
Net Cash (Debt) | -1,207 | -821.92 | -1,544 | -74.97 | -325.89 |
Net Cash Per Share | -19.74 | -13.44 | -25.25 | -1.29 | -6.38 |
Filing Date Shares Outstanding | 61.17 | 61.16 | 61.16 | 61.16 | 51.05 |
Total Common Shares Outstanding | 61.17 | 61.16 | 61.16 | 61.16 | 51.05 |
Working Capital | -128.6 | 992.77 | 657.24 | 1,541 | 1,358 |
Book Value Per Share | 122.09 | 99.14 | 78.55 | 66.80 | 62.78 |
Tangible Book Value | 4,840 | 4,352 | 2,877 | 4,080 | 3,110 |
Tangible Book Value Per Share | 79.12 | 71.16 | 47.04 | 66.71 | 60.92 |
Land | - | 81.79 | 81.79 | 81.79 | 81.79 |
Buildings | - | 479.37 | 475 | 472.35 | 464.4 |
Machinery | - | 1,606 | 1,427 | 1,248 | 984.82 |
Construction In Progress | - | 1,860 | 1,206 | 647.09 | 142.29 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.